99% Savings - Buy Just @1 Rs X
Reclimet Tablet (15) is a prescription drug, available for use as Tablet. Diabetes are some of its major therapeutic uses. The alternative uses of Reclimet Tablet (15) have also been explained below.
The optimal dosage of Reclimet Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Reclimet Tablet (15) include Nausea or vomiting, Bradycardia, Constipation. Some other side effects of Reclimet Tablet (15) have been listed ahead. These side effects of Reclimet Tablet (15) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Reclimet Tablet (15) is Moderate for pregnant women and Safe for women who are breastfeeding. It is important to know if Reclimet Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Reclimet Tablet (15) related warnings section.
Other contraindications of Reclimet Tablet (15) have been discussed in the sections ahead.
Drug reaction of Reclimet Tablet (15) with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Reclimet Tablet (15) is safe while driving, and is is addictive in nature.
Reclimet Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Reclimet Tablet (15) safe for pregnant women?
Pregnant women may experience moderate side effects from Reclimet. It is best to stop taking Reclimet immediately and inform your doctor if you notice any discomfort.
Is the use of Reclimet Tablet (15) safe during breastfeeding?
Reclimet does not show any side effects in breastfeeding women.
What is the effect of Reclimet Tablet (15) on the Kidneys?
There can be some harmful effects on your kidneys after taking Reclimet. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Reclimet Tablet (15) on the Liver?
There may be an adverse effect on the liver after taking Reclimet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Reclimet Tablet (15) on the Heart?
Effects of Reclimet on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Reclimet Tablet (15) unless your doctor advises you to do so -
Is this Reclimet Tablet (15) habit forming or addictive?
No, there is no any evidence that Reclimet Tablet (15) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Reclimet Tablet (15) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Reclimet Tablet (15) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Reclimet Tablet (15) in mental disorders is not effective.
Interaction between Food and Reclimet Tablet (15)
Taking Reclimet Tablet (15) with food does not harm your health.
Interaction between Alcohol and Reclimet Tablet (15)
Consult your doctor before consuming alcohol while taking Reclimet Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826